| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-21 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-218 | Paclitaxel | ovarian cancer | Sensitive | High | 18823650 | |
| miR-213 | Paclitaxel | ovarian cancer | Resistant | High | 19237188 | |
| miR-21 | Paclitaxel | breast cancer | Sensitive | Low | 19633292 | |
| miR-21 | Paclitaxel | breast carcinoma | Resistant | Low | 20082533 | |
| miR-21 | Paclitaxel | glioblastoma | Resistant | Low | 20113523 | |
| miR-217 | Paclitaxel | ovarian cancer | Resistant | High | 23697367 | |
| miR-210 | Paclitaxel | cervical cancer | Resistant | Low | 23778521 | |
| miR-210 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-2114 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-214 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-219-2 | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-218 | Paclitaxel | Cancer | Resistant | High | 24220856 | |
| miR-21 | Paclitaxel | epithelial ovarian cancer | Associated | Low | 24977712 | |
| miR-217 | Paclitaxel | melanoma | Sensitive | Low | 25138213 | |
| miR-218 | Paclitaxel | breast cancer | Sensitive | Low | 25900794 | |
| miR-21 | Paclitaxel | - | Resistant | Low | 26555418 |